About this event

  • Date and time Mon 22 Jan 2024 from 8:30am to 23 Jan 2024 at 5:00pm
  • Location Royal Society of Medicine
  • Organised by Nephrology

Join us for this two-day meeting, a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis (GN) Clinical Study Group (CSG), showcasing developments in the field of inflammatory renal disease, advancements in basic science, registries, therapeutic targets and clinical trials in glomerulonephritis. 

By attending the meeting, participants will gain an in-depth understanding on the pathological mechanisms and therapeutic targets in Glomerulonephritis. Topics will be reviewed and delivered through interactive lectures, case based and panel discussions. 

This meeting is a collaboration between scientists, clinicians, trialist and pharm showcasing pioneering developments in inflammatory renal diseases. 

By attending the meeting, you will:

  • Gain an increased awareness of developments in refining definitions of disease entities in inflammatory renal diseases
  • Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis
  • Enhance your knowledge of management strategies for Glomerulonephritis
  • Be aware of developments in techniques in identifying renal autoimmune diseases
  • Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis 
  • Gain updates on UK Kidney Research GN Clinical study Group

 

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

 

We would like to thank our sponsors AstraZeneca, CSL Vifor, Novartis and Thornton & Ross STADA Group who have provided sponsorship towards this independent Programme.

This activity has also been supported by Alentis Therapeutics, Alpine Immune Sciences, argenx, Arrowhead Pharmaceutical, Dimerix, Otsuka, Roche and Vera Therapeutics in the form of educational grants.

The companies listed above have had no editorial input into or control over the agenda, content development or choice of speakers for the event.

Due to this funding, the Nephrology Section is pleased to offer this event at a subsidised fee for participants.

Show Virtual / In Person rates

Agenda

View the programme: Day 1 - Advancing Research & Clinical Practice in Glomerulonephritis (in person) 22 January 2024

Registration, tea and coffee
Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Session 1: Taking new therapies from clinical trials to the clinic

Chairs: Professor Liz Lightstone, Professor of Renal Medicine, Imperial College Healthcare NHS Trust

Professor Alan Salama, Consultant Nephrologist, University College London Hospitals NHS Foundation Trust

The roles of National Institute for Health Research (NIHR) and the Glomerulonephritis Clinical Study Group (GN CSG) in delivering new trials in glomerular disease

Professor David Wheeler, Professor of Kidney Medicine, University College London Hospitals NHS Foundation Trust

Dr Rachel Jones, Consultant Nephrologist, Cambridge University Hospitals NHS Foundation Trust

Evaluation of new approved therapies for rare glomerular disease by National Institute for Health and Care Excellence (NICE)

Dr James Fotheringham, Consultant Nephrologist, Sheffield Kidney Institute and the University of Sheffield 

NHS commissioning of innovative therapies: Learning from rheumatology?

Dr Peter Lanyon, Consultant Rheumatologist, Nottingham University Hospitals NHS Trust and Honorary Professor, School of Medicine, University of Nottingham 

Patient panel: Living with a rare disease

Chairs: Professor Liz Lightstone, Professor of Renal Medicine, Imperial College Healthcare NHS Trust

Professor Jonathan Barratt, Professor of Renal Medicine, University Hospitals of Leicester NHS Trust

Tea and coffee break

Session 2: Glomerular diseases: From the bench to the bedside

Chairs: Dr Katie Vinen, Consultant Nephrologist, King’s College Hospital NHS Foundation Trust

Dr Rupert Beale, Honorary Consultant, Royal Free London NHS Foundation Trust and Clinician Scientist Group Leader, The Francis Crick Institute

Inflammatory pathways in Glomerular disease

Professor David Thomas, Professor of Renal Medicine, University of Cambridge 

Novel assessment of glomerular pathology

Dr Katherine Bull, Academic Nephrologist, University of Oxford

Taking the UK Rare Renal Registry to the next level

Professor Danny Gale, Professor of Nephrology, University College London Hospitals NHS Foundation Trust 

Moving academic research into the commercial arena

Professor Moin Saleem, Professor of Paediatric Renal Medicine, University of Bristol

Lunch break

Session 3: Developing partnerships and platforms for clinical research

Chairs: Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Professor David Wheeler, Professor of Kidney Medicine, University College London Hospitals NHS Foundation Trust

Investigator led studies in glomerulonephritis and vasculitis

Dr Rachel Jones, Consultant Nephrologist, Cambridge University Hospitals NHS Foundation Trust 

Dr Chee Kay Cheung, Consultant Nephrologist and Honorary Associate Professor, University Hospitals of Leicester NHS Trust

The Protect V platform approach

Dr Rona Smith, Senior Research Associate and Honorary Consultant in Nephrology and Vasculitis, Cambridge University Hospitals NHS Foundation Trust

The UK Kidney Ecosystem initiative

Dr Louise Oni, Senior Lecturer in Paediatric Nephrology and Honorary Paediatric Nephrologist, Alder Hey Children’s NHS Foundation Trust

Emerging newer therapies, research initiatives and collaborations: Industry Nephrologist opportunities and experiences

Professor Iain McPhee, Executive Group Medical Director, Nephrology, AstraZeneca

Dr Thomas Hiemstra, Fellow and Senior Director, Clinical Development, GlaxoSmithKline

Dr Shaun Flint, Physician, Clinical Development, CSL Vifor, Zurich, Switzerland

Professor Bruce Hendry, Executive Director, Travere Therapeutics 

Panel discussion

Panel: Dr Louise Oni, Senior Lecturer in Paediatric Nephrology and Honorary Paediatric Nephrologist, Alder Hey Children’s NHS Foundation Trust

Dr Rona Smith, Senior Research Associate and Honorary Consultant in Nephrology and Vasculitis, Cambridge University Hospitals NHS Foundation Trust

Professor Iain McPhee, Executive Group Medical Director, Nephrology, AstraZeneca

Dr Thomas Hiemstra, Fellow and Senior Director, Clinical Development, GlaxoSmithKline

Dr Shaun Flint, Physician, Clinical Development, CSL Vifor, Zurich, Switzerland

Professor Bruce Hendry, Executive Director, Travere Therapeutics

Tea and coffee break

Session 4: Collaborating to innovate research in the UK

Chairs: Professor Sian Griffin, Consultant Nephrologist, University Hospital of Wales, Cardiff

Dr Stephen McAdoo, Nephrologist and Clinical Senior Lecturer, Imperial College Healthcare NHS Trust

The role of Kidney Research UK (KRUK) in facilitating successful partnerships with industry

Mr William Cole, Life Science Partnership Manager, Kidney Research UK

Funding schemes to support academic-industry collaborations

Professor Lorraine Harper, Professor of Nephrology, University of Birmingham

How can the NHS work with industry to promote innovation?

Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust and NHS England National Clinical Director of Renal Medicine

How can industry work with the NHS to promote innovation?

Professor Robert Unwin, Chief Scientist, AstraZeneca

Panel discussion

Panel: Professor Lorraine Harper, Professor of Nephrology, University of Birmingham

Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust and NHS England National Clinical Director of Renal Medicine

Professor Liz Lightstone, Professor of Renal Medicine, Imperial College Healthcare NHS Trust 

Professor Robert Unwin, Chief Scientist, AstraZeneca

Closing remarks

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Completion of evaluation forms

Close of meeting
View the programme: Day 2 - Frontiers in Glomerulonephritis (in person) 23 January 2024

Registration, tea and coffee
Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Session 1: Epidemiology, innovation and novel treatment targets

Chairs: Dr Tina Chrysochou, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance

Dr Chee Kay Cheung, Consultant Nephrologist and Honorary Associate Professor, University Hospitals of Leicester NHS Trust

Outcome of Glomerulonephritis from the National Registry of Rare Kidney Diseases (RaDaR)

Professor Danny Gale, Professor of Nephrology, University College London Hospitals NHS Foundation Trust 

Machine learning, Pathomics and the future for kidney biopsies

Professor Peter Boor, Pathologist, Institute of Pathology 

Complement: Therapeutic milestone in glomerular diseases

Professor David Kavanagh, Professor of Complement Therapeutics and Honorary Consultant Nephrologist, Newcastle University, National Renal Complement Therapeutics Centre

B cell targets in glomerular diseases

Professor David Jayne, Professor of Clinical Autoimmunity, Cambridge University Hospitals NHS Foundation Trust 

Tea and coffee break

Session 2: Therapeutic advancements in glomerular disease

Chairs: Dr Rona Smith, Senior Research Associate and Honorary Consultant in Nephrology and Vasculitis, Cambridge University Hospitals NHS Foundation Trust

Dr Stephen McAdoo, Nephrologist and Clinical Senior Lecturer, Imperial College Healthcare NHS Trust

Immunoglobulin A (IgA) Nephropathy

Professor Jonathan Barratt, Professor of Renal Medicine, University Hospitals of Leicester NHS Trust

Vasculitis

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Complement 3 (C3) Glomerulopathy

Dr Edwin Wong, Consultant Nephrologist, National Renal Complement Therapeutics Centre

Lupus Nephritis

Professor Liz Lightstone, Professor of Renal Medicine, Imperial College Healthcare NHS Trust

Paediatric Glomerulonephritis

Dr Louise Oni, Senior Lecturer in Paediatric Nephrology and Honorary Paediatric Nephrologist, Alder Hey Children’s NHS Foundation Trust

Lunch break

Session 3: Nephrotic Syndrome: From bench to bedside

Chairs: Professor Megan Griffith, Consultant Nephrologist, Imperial College Healthcare NHS Trust 

Dr Francesco Rainone, Consultant Nephrologist, Northern Care Alliance NHS Foundation Trust

Membranous Nephropathy

Professor Pierre Ronco, Emeritus Professor of Nephrology, Sorbonne University Hospital and The National Institute of Health and Medical Research, Paris, France

Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) in children

Professor Moin Saleem, Professor of Paediatric Renal Medicine, University of Bristol

MCD and FSGS in adults

Dr Lisa Willcocks, Consultant Nephrologist, Cambridge University Hospitals NHS Foundation Trust 

Tea and coffee break

Session 4: Cases and controversies

Chairs: Professor Terry Cook, Emeritus Professor of Renal Pathology, Imperial College Healthcare NHS Trust Imperial College Healthcare NHS Trust 

Dr Silke Brix, Consultant Nephrologist, Manchester University NHS Foundation Trust

Cases and expert panel discussion

Panel: Professor Pierre Ronco, Emeritus Professor of Nephrology, Sorbonne University Hospital and The National Institute of Health and Medical Research, Paris, France

Professor Alan Salama, Consultant Nephrologist, University College London Hospitals NHS Foundation Trust

Professor Liz Lightstone, Professor of Renal Medicine, Imperial College Healthcare NHS Trust

Dr Louise Oni, Senior Lecturer in Paediatric Nephrology and Honorary Paediatric Nephrologist, Alder Hey Children’s NHS Foundation Trust

Case presenters: Dr Lydia Roberts, Specialised Foundation Programme Foundation Year 2 Doctor, University Hospitals of Leicester NHS Trust

Dr Kevin Loudon, Consultant Nephrologist, Addenbrooke's Hospital

Dr Lucy Francis, Clinical Research Fellow, Addenbrooke's Hospital

Dr Chee Kay Cheung, Consultant Nephrologist and Honorary Associate Professor, University Hospitals of Leicester NHS Trust

Closing remarks

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Dr Rachel Jones, Consultant Nephrologist, Cambridge University Hospitals NHS Foundation Trust

Professor Jonathan Barratt, Professor of Renal Medicine, University Hospitals of Leicester NHS Trust

Completion of evaluation forms

Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

 

 

Registration for this event will close at 1:00am on Sunday 21 September 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Domus - reception

While you’re attending this event

Why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more